Targeting Mesothelin With Modified T Cells

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2015-069
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Mesothelin-Targeting Chimeric Antigen Receptor–modified T Cells by piggyBac Transposon System Suppress the Growth of Bile Duct Carcinoma

Tumor Biology
MedicineCancer Research
2017English

Correction: Modified CAR T Cells Targeting Membrane-Proximal Epitope of Mesothelin Enhances the Antitumor Function Against Large Solid Tumor

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2020English

Targeting Glioblastoma With CAR T Cells

Cancer Discovery
Oncology
2017English

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

Cancer Discovery
Oncology
2015English

Reduced Shedding of Surface Mesothelin Improves Efficacy of Mesothelin-Targeting Recombinant Immunotoxins

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Author Correction: Targeting Cardiac Fibrosis With Engineered T Cells

Nature
Multidisciplinary
2019English

Combining Anti-Ctla4 With RG7787, an Immunotoxin Targeting Mesothelin, Promotes Tumor Eradication

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2012English

Modified T Cells Home to Brain Tumors

Cancer Discovery
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy